These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25363393)

  • 1. Latent classes of course in Alzheimer's disease and predictors: the Cache County Dementia Progression Study.
    Leoutsakos JM; Forrester SN; Corcoran CD; Norton MC; Rabins PV; Steinberg MI; Tschanz JT; Lyketsos CG
    Int J Geriatr Psychiatry; 2015 Aug; 30(8):824-32. PubMed ID: 25363393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes.
    Haaksma ML; Calderón-Larrañaga A; Olde Rikkert MGM; Melis RJF; Leoutsakos JS
    Int J Geriatr Psychiatry; 2018 Aug; 33(8):1057-1064. PubMed ID: 29761569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trajectories and risk factors of dementia progression: a memory clinic cohort followed up to 3 years from diagnosis.
    Edwin TH; Strand BH; Persson K; Engedal K; Selbæk G; Knapskog AB
    Int Psychogeriatr; 2021 Aug; 33(8):779-789. PubMed ID: 33213607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease.
    Rosenberg PB; Mielke MM; Han D; Leoutsakos JS; Lyketsos CG; Rabins PV; Zandi PP; Breitner JC; Norton MC; Welsh-Bohmer KA; Zuckerman IH; Rattinger GB; Green RC; Corcoran C; Tschanz JT
    Int J Geriatr Psychiatry; 2012 Dec; 27(12):1248-57. PubMed ID: 22374884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification, Prediction, and Concordance of Cognitive and Functional Progression in Patients with Mild Cognitive Impairment in the United States: A Latent Class Analysis.
    Mouchet J; Betts KA; Georgieva MV; Ionescu-Ittu R; Butler LM; Teitsma X; Delmar P; Kulalert T; Zhu J; Lema N; Desai U
    J Alzheimers Dis; 2021; 82(4):1667-1682. PubMed ID: 34219723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutritional Status is Associated with Faster Cognitive Decline and Worse Functional Impairment in the Progression of Dementia: The Cache County Dementia Progression Study1.
    Sanders C; Behrens S; Schwartz S; Wengreen H; Corcoran CD; Lyketsos CG; Tschanz JT
    J Alzheimers Dis; 2016 Feb; 52(1):33-42. PubMed ID: 26967207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline.
    Hochstetler H; Trzepacz PT; Wang S; Yu P; Case M; Henley DB; Degenhardt E; Leoutsakos JM; Lyketsos CG
    J Alzheimers Dis; 2016; 50(1):271-82. PubMed ID: 26639960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageing.
    Sona A; Zhang P; Ames D; Bush AI; Lautenschlager NT; Martins RN; Masters CL; Rowe CC; Szoeke C; Taddei K; Ellis KA;
    Int Psychogeriatr; 2012 Feb; 24(2):197-204. PubMed ID: 21749739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic Medication and Cognitive, Functional, and Neuropsychiatric Outcomes in Alzheimer's Disease (AD).
    Oh ES; Rosenberg PB; Rattinger GB; Stuart EA; Lyketsos CG; Leoutsakos JS
    J Am Geriatr Soc; 2021 Apr; 69(4):955-963. PubMed ID: 33382921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study.
    Tschanz JT; Corcoran CD; Schwartz S; Treiber K; Green RC; Norton MC; Mielke MM; Piercy K; Steinberg M; Rabins PV; Leoutsakos JM; Welsh-Bohmer KA; Breitner JC; Lyketsos CG
    Am J Geriatr Psychiatry; 2011 Jun; 19(6):532-42. PubMed ID: 21606896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of general medical health on Alzheimer's progression: the Cache County Dementia Progression Study.
    Leoutsakos JM; Han D; Mielke MM; Forrester SN; Tschanz JT; Corcoran CD; Green RC; Norton MC; Welsh-Bohmer KA; Lyketsos CG
    Int Psychogeriatr; 2012 Oct; 24(10):1561-70. PubMed ID: 22687143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
    Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
    Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological predictors of dementia in a three-year follow-up period: data from the LADIS study.
    Madureira S; Verdelho A; Moleiro C; Ferro JM; Erkinjuntti T; Jokinen H; Pantoni L; Fazekas F; Van der Flier W; Visser M; Waldemar G; Wallin A; Hennerici M; Inzitari D
    Dement Geriatr Cogn Disord; 2010; 29(4):325-34. PubMed ID: 20389074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trajectories of depressive symptoms and their relationship to the progression of dementia.
    Barca ML; Persson K; Eldholm R; Benth JŠ; Kersten H; Knapskog AB; Saltvedt I; Selbaek G; Engedal K
    J Affect Disord; 2017 Nov; 222():146-152. PubMed ID: 28704802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CERAD neuropsychological assessment battery total score detects and predicts Alzheimer disease dementia with high diagnostic accuracy.
    Wolfsgruber S; Jessen F; Wiese B; Stein J; Bickel H; Mösch E; Weyerer S; Werle J; Pentzek M; Fuchs A; Köhler M; Bachmann C; Riedel-Heller SG; Scherer M; Maier W; Wagner M;
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):1017-28. PubMed ID: 23759289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cardiovascular medications on rate of functional decline in Alzheimer disease.
    Rosenberg PB; Mielke MM; Tschanz J; Cook L; Corcoran C; Hayden KM; Norton M; Rabins PV; Green RC; Welsh-Bohmer KA; Breitner JC; Munger R; Lyketsos CG
    Am J Geriatr Psychiatry; 2008 Nov; 16(11):883-92. PubMed ID: 18978249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of education on the progression of early- versus late-stage mild cognitive impairment.
    Ye BS; Seo SW; Cho H; Kim SY; Lee JS; Kim EJ; Lee Y; Back JH; Hong CH; Choi SH; Park KW; Ku BD; Moon SY; Kim S; Han SH; Lee JH; Cheong HK; Na DL
    Int Psychogeriatr; 2013 Apr; 25(4):597-606. PubMed ID: 23207181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of premorbid IQ and education on progression of Alzheimer's disease.
    Pavlik VN; Doody RS; Massman PJ; Chan W
    Dement Geriatr Cogn Disord; 2006; 22(4):367-77. PubMed ID: 16954693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment.
    Koppara A; Wolfsgruber S; Kleineidam L; Schmidtke K; Frölich L; Kurz A; Schulz S; Hampel H; Heuser I; Peters O; Reischies FM; Jahn H; Luckhaus C; Hüll M; Gertz HJ; Schröder J; Pantel J; Rienhoff O; Rüther E; Henn F; Wiltfang J; Maier W; Jessen F; Kornhuber J; Wagner M
    J Alzheimers Dis; 2016; 49(2):547-60. PubMed ID: 26484902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the Cache County Dementia Progression Study.
    Peters ME; Schwartz S; Han D; Rabins PV; Steinberg M; Tschanz JT; Lyketsos CG
    Am J Psychiatry; 2015 May; 172(5):460-5. PubMed ID: 25585033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.